Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Selpercatinib and the Crossover Conundrum: Potential Impact of Postprogression Therapies on Overall Survival.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 17, 2026
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 26, 2026
FDA Approval Summary: Retifanlimab for the treatment of adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 11, 2026
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 24, 2025
FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 06, 2025
FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 28, 2025
FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 26, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 19, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2025
FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2025
Last Updated: 09/26/2026